Antibody Validations

Antibody Validations

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
About this Gateway

Antibodies are one of the most frequently used tools in any life sciences laboratory. Antibody validation is crucial to provide the information needed in order to reliably interpret the results of experiments. Validating an antibody is important work, and yet the results of these validations rarely get published. You can refer to our guidelines on preparing Antibody Validation Articles, and download the article template.

The Antibody Validations gateway provides a platform where researchers and companies can both publish their antibody validation studies regardless of the outcome, and look up existing validation articles for antibodies of their interest. In this way, we hope to enhance the reliability and reproducibility of antibodies in scientific research.

Antibody validation articles cover a variety studies:

  • New antibodies; either against a new target or a new antibody raised against an existing target.
  • New applications for existing antibodies; either in a new biological system or a new application tested within an existing/previously tested biological system.
  • Existing antibodies applied to a new biological system; new organism/tissue/cell type.
  • Validations of previously tested antibodies that are carried out in more depth than before, in one or more applications.
  • Validations of groups of antibodies raised against the same target.
  • Antibodies that failed to meet the validation criteria.
  • Replication studies that confirm or dispute previously published validations.

Antibody Validation articles are considered a unique article type in F1000Research.

Read the Editorial by the Guest Editors for more details.

Gateway Advisors
  • Matt Helsby
    CiteAb, UK

  • Mei Leung
    PeproTech EC Ltd, London, UK

  • Andrew Chalmers
    University of Bath, UK

Advisory Board
  • Carl Ascoli
    Rockland Immunochemicals, Boyertown, PA, USA

  • Tim Bernard
    Pivotal Scientific Ltd, Oxfordshire, UK

  • Mike Browning
    PhosphoSolutions, Aurora, CO, USA

  • Lynda Erskine
    University of Aberdeen, UK

  • Simon Glerup
    Aarhus University, Denmark

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.